Single Doses of GSK3008348 in Idiopathic Pulmonary Fibrosis (IPF) Participants Using Positron Emission Tomography (PET) Imaging

Stopped Sufficient information was gathered from cohort 1 to terminate the study without proceeding to optional cohort 2.

Conditions

• Idiopathic Pulmonary Fibrosis

Interventions

• DRUG: GSK3008348
• DRUG: Placebo
• DRUG: [18F]-FBA-A20FMDV2

Sponsor

GlaxoSmithKline